Since the ATR‐Chk1 pathway is crucial to overcome replication stress and for cell cycle arrest in the event of DNA damage, Chk1 is potentially an important therapeutic target in tumors, which frequently harbor mutated tumor suppressors such as p53 and Rb. This evidence concerns the gene TP53 and neoplasm.